Insider · CIK 0001754280
Karin Jooss
Files at FATE (FATE THERAPEUTICS INC), GRTS (Gritstone bio, Inc.). First filing May 17, 2024, latest May 17, 2024.
In brief
Karin Jooss files SEC Form 4 as director and officer at GRTS (Gritstone bio, Inc.), and also at FATE (FATE THERAPEUTICS INC). Since May 17, 2024, Karin Jooss has reported 0 open-market buys worth $0 and 1 open-market sell worth $10k, the latest filed on May 17, 2024.
A track record needs three past buys with six months of prices behind them; Karin Jooss has 0, so none is measured yet.
The newest scored trade: sold $10k of GRTS on May 16, 2024, filed May 17, 2024, scored 30 (weak).
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | FATE FATE THERAPEUTICS INC | AGrant or award Stock Option (Right to Buy)derivative | +87,900 | $0.00 | $0 | 87,900 | Jun 15, 2026 |
| May 29, 2025 | FATE FATE THERAPEUTICS INC | AGrant or award Stock Option (Right to Buy)derivative | +55,000 | $0.00 | $0 | 55,000 | May 30, 2025 |
| Jun 7, 2024 | FATE FATE THERAPEUTICS INC | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 11, 2024 |
| May 15, 2024 | GRTS Gritstone bio, Inc. | AGrant or award Common Stock | +27,128 | $0.00 | $0 | 697,275 | May 17, 2024 |
| May 16, 2024 | GRTS Gritstone bio, Inc. | SOpen-market sale Common Stock | -13,749 | $0.75 | $10k | 683,526 | May 17, 2024 |
| May 15, 2024 | GRTS Gritstone bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +235,000 | $0.00 | $0 | 235,000 | May 17, 2024 |
| Feb 1, 2024 | GRTS Gritstone bio, Inc. | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 648,851 | Feb 5, 2024 |
| Feb 1, 2024 | GRTS Gritstone bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +235,000 | $0.00 | $0 | 235,000 | Feb 5, 2024 |
Questions about Karin Jooss
Answered from the filings on this page, as of the latest one.
Is Karin Jooss buying or selling?
Not in the last 12 months. Karin Jooss's latest open-market trade on SEC Form 4 was sold $10k of GRTS on May 16, 2024.
How did Karin Jooss's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Karin Jooss has 0.
Where does Karin Jooss file Form 4?
Karin Jooss has filed Form 4 at GRTS (Gritstone bio, Inc.) as SEE REMARKS; FATE (FATE THERAPEUTICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.